Clinical Trials Directory

Trials / Completed

CompletedNCT02585128

Predictors of Postoperative Delirium After Transcatheter Aortic Valve Implantation

Incidence and Risk Factors of Acute Postoperative Confusion State After Trans-catheter Aortic Valve Implantation (TAVI)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
201 (actual)
Sponsor
Cardiocentro Ticino · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Patients undergoing transcatheter aortic valve implantation (TAVI) have distinctive characteristics: they are old, frail, with several co-morbidities and take multiple medications. Hemodynamic instability, cerebral embolism, sedation, general anesthesia and hospitalization in intensive care expose those patients to postprocedural delirium. Acute neurocognitive dysfunctions are associated with adverse outcomes in these population. The objective of this study is to determine the incidence of delirium and neurocognitive disorders in elderly patients after TAVI.

Conditions

Interventions

TypeNameDescription
OTHERDelirium assessmentDuring the first post-procedural five days all patients will be evaluated on a daily basis for delirium occurrence by the CAM (Confusion Assessment Method) or CAM - ICU (Confusion Assessment Method - Intensive Care Unit)
OTHERMMSE (Mini Mental State Examination)
OTHERBarthel index
OTHERHADS (Hospital Anxiety and Depression Scale)
OTHERMNA-SF (Mini Nutritional Assessment - Short Form)
DEVICENIRS (Near-Infrared Spectroscopy)Regional cerebral oxygen saturation monitoring during TAVI procedure
OTHERCIRS (Cumulative Illness Rating Scale)

Timeline

Start date
2015-09-01
Primary completion
2019-05-01
Completion
2021-01-01
First posted
2015-10-23
Last updated
2024-04-18

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02585128. Inclusion in this directory is not an endorsement.